Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Fever × pegfilgrastim × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Neutropenia 3 Lymphoma, Non-Hodgkin 2 Ovarian Neoplasms 1 Malignant Solid Tumors 1 Lymphoma 1 Lung Neoplasms 1 Fever 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Vancomycin 2 Ceftazidime 2 pegfilgrastim 1 Teicoplanin 1 Piperacillin, Tazobactam Drug Combination 1 Meropenem 1 Cefepime 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Amgen

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡